Clik here to view.
EMA clears Roche’s polyarticular juvenile idiopathic arthritis drug
www.simplesharebuttons.comShare: EMA clears Roche’s polyarticular juvenile idiopathic arthritis drug The European Medicines Agency has cleared Roche’s RoACTEMRA for the treatment of a rare form of...
View ArticleClik here to view.
European Medicines Agency …Clinical trials in human medicines
www.simplesharebuttons.comShare: The European Medicines Agency relies on the results of clinical trials carried out by pharmaceutical companies to reach its opinions on the authorisation of...
View ArticleClik here to view.
Road map to 2015, The European Medicines Agency’s contribution to science,...
www.simplesharebuttons.comShare: One of the European Medicines Agency’s long-term strategic goals is to foster researchand the uptake of innovative methods in the development of medicines....
View ArticleClik here to view.
GMP Oversight of Medicines Manufacturers in the European Union
Share: A System of Equivalent Member States, a Coordinating Agency and a Centralized Institution The regulatory system for supervision of pharmaceutical manufacturers and GMP inspection in the...
View ArticleClik here to view.
EMA publishes finalised Process Validation Guideline for Biotech Products
Share: Approximately two years ago the EMA published a draft guideline on process validation for the manufacture of biotech products. Now the final guideline has been published under the title...
View ArticleClik here to view.
EMA’s new Draft Guideline on the Sterilisation of Medicinal Products, APIs,...
Share: For medicinal products administrated in sterile form, the process to reduce the microbial level is a critical manufacturing step with regard to quality. The EMA has recently published the draft...
View ArticleClik here to view.
EMA publishes Q&A on data required for sterilized primary packaging materials...
Share: The European Medicines Agency, EMA, recently published questions and answers on what data is required for sterilisation processes of primary packaging materials subsequently used in an aseptic...
View ArticleClik here to view.
EMA reviews Medicines manufactured at U.S. Company
Share: Following the issuance of two Non-Compliance Reports for two sites of the US based company, EMA has started a review of medicines manufactured by Pharmaceutics International Inc., USA. The...
View ArticleClik here to view.
Practical Implementation of the Control of Elemental Impurities: EMA’s new...
Share: One and a half year after its publication, the ICH Q3D guideline still raises many questions. The EMA has recently published a guideline draft aiming at clarifying the practical implementation...
View ArticleClik here to view.
EMA/ FDA Mutual Recognition Agreement on drug facility inspections moving...
Share: EMA/ FDA Mutual Recognition Agreement moving forward A possible agreement between the EMA and the US FDA on mutual recognition agreement on drug facility inspections could already be signed...
View ArticleClik here to view.
EMA issues new Guideline on “Chemistry of Active Substances”
Share: The new EMA “Guideline on the chemistry of active substances” represents the current state of the art in regulatory practice and fits into the context of the ICH Guidelines Q8-11. Find out what...
View ArticleClik here to view.
EMA publishes Q&A on Health Based Exposure Limits – Does the 1/1000 dose...
Share: In 2014 the European Medicines Agency (EMA) issued the Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in...
View ArticleClik here to view.
EMA modernizing the orphan designation process
Share: EMA modernizing the orphan designation process On June 19, 2018, the European Medicines Agency (EMA) launched a new secure online portal for Orphan Designation (OD) applications. The portal,...
View Article